Recursion Pharmaceuticals RXRX
NASDAQ RXRX
$4.03 +0.33 (+8.78%)
As of: Sep 29, 2026 · 3:59 PM EDT

Recursion Pharmaceuticals (RXRX) Receivables - Net (2020 - 2022)

Updated

Recursion Pharmaceuticals' Receivables - Net came in at $21,000 for Q2 2022, down 57.1% from $49,000 a year earlier and down 38.2% from the prior quarter.

Analysis

Recursion Pharmaceuticals (RXRX) Receivables - Net (2020 - 2022) Analysis & Trends

At the end of FY2021, Recursion Pharmaceuticals' Receivables - Net was $34,000, down 78.2% from FY2020.

  • Going back by year, Receivables - Net was $156,000 in FY2020.
  • Year-over-year, Receivables - Net has declined for three consecutive quarters.
  • Business Quant data shows RXRX's Receivables - Net at $34,000 (Q1 2022), $34,000 (Q4 2021) and $34,000 (Q3 2021) in the three quarters before Q2 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Recursion Pharmaceuticals 1.98 Bn -627.04 Mn -3.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 21,000.00
Mar 31, 2022 34,000.00
Dec 31, 2021 34,000.00
Sep 30, 2021 34,000.00
Jun 30, 2021 49,000.00
Mar 31, 2021 71,000.00
Dec 31, 2020 156,000.00
API Access

Recursion Pharmaceuticals Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=RXRX&period=max&api_key=YOUR_API_KEY